6-Amino-3,6-dideoxy-5-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-β-L-lyxo-heptopyranosyl)-2-O-methyl-3-(methylamino)-D-myo-inositol

6-Amino-3,6-dideoxy-5-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-β-L-lyxo-heptopyranosyl)-2-O-methyl-3-(methylamino)-D-myo-inositol Struktur
122517-24-2
CAS-Nr.
122517-24-2
Englisch Name:
6-Amino-3,6-dideoxy-5-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-β-L-lyxo-heptopyranosyl)-2-O-methyl-3-(methylamino)-D-myo-inositol
Synonyma:
Fortimicin KR;6-Amino-3,6-dideoxy-5-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-β-L-lyxo-heptopyranosyl)-2-O-methyl-3-(methylamino)-D-myo-inositol;D-myo-Inositol, 6-amino-3,6-dideoxy-5-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-β-L-lyxo-heptopyranosyl)-2-O-methyl-3-(methylamino)- (9CI)
CBNumber:
CB42274090
Summenformel:
C15H32N4O5
Molgewicht:
348.43838
MOL-Datei:
122517-24-2.mol

6-Amino-3,6-dideoxy-5-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-β-L-lyxo-heptopyranosyl)-2-O-methyl-3-(methylamino)-D-myo-inositol Eigenschaften

Siedepunkt:
532.0±50.0 °C(Predicted)
Dichte
1.26±0.1 g/cm3(Predicted)
pka
13.45±0.70(Predicted)

Sicherheit

6-Amino-3,6-dideoxy-5-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-β-L-lyxo-heptopyranosyl)-2-O-methyl-3-(methylamino)-D-myo-inositol Chemische Eigenschaften,Einsatz,Produktion Methoden

6-Amino-3,6-dideoxy-5-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-β-L-lyxo-heptopyranosyl)-2-O-methyl-3-(methylamino)-D-myo-inositol Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


6-Amino-3,6-dideoxy-5-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-β-L-lyxo-heptopyranosyl)-2-O-methyl-3-(methylamino)-D-myo-inositol Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 0)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate

  • 6-Amino-3,6-dideoxy-5-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-β-L-lyxo-heptopyranosyl)-2-O-methyl-3-(methylamino)-D-myo-inositol
  • Fortimicin KR
  • D-myo-Inositol, 6-amino-3,6-dideoxy-5-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-β-L-lyxo-heptopyranosyl)-2-O-methyl-3-(methylamino)- (9CI)
  • 122517-24-2
Copyright 2019 © ChemicalBook. All rights reserved